glp-1 injectables How medications are transforming diabetes and weight loss treatment Microdose GLP-1 Injections - Team

Providers pivoted

In a clinical trial, those who underwent a technique called duodenal mucosal resurfacing regained far less weight compared to others after discontinuing the medication

The insurer had spent over $300 million on GLP-1 medications, with projections showing costs approaching $1 billion by 2026 if trends continued

no real-time or emergency access

This suggests that the drug does not preferentially target muscle for catabolism, but rather that muscle loss is a bystander effect of the profound weight reduction

Anti-inflammatory Effects: GLP-1 may reduce systemic inflammation markers, with downstream benefits for immune aging and disease resilience